Big Move For Denali Therapeutics Inc.

Thu, Aug 06, 2020 at 05:30 PM
Big Move For Denali Therapeutics Inc.

Denali Therapeutics Inc. (DNLI:NASDAQ) soared at $31.66, representing a gain of 36.2%. On Wed 05 Aug 20, DNLI:NASDAQ hit a New 2-Week Intraday Low of $22.75. The stock appeared on our News Catalysts scanner on Thu 06 Aug 20 at 10:04 AM in the 'PATNERSHIP' category. From Wed 22 Jul 20, the stock recorded 40.00% Up Days and 45.45% Green Days

The share price of the company has been moving sideways in recent weeks.

About Denali Therapeutics Inc. (DNLI:NASDAQ)

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.